Control participants of randomised trials: an often forgotten, vulnerable population
Lancet Haematol
.
2022 Sep;9(9):e634-e636.
doi: 10.1016/S2352-3026(22)00254-X.
Authors
Ghulam Rehman Mohyuddin
1
,
Nikita Mehra
2
,
Bettina Ryll
3
,
Vinay Prasad
4
Affiliations
1
Division of Hematology, Huntsman Cancer Center, University of Utah, Salt Lake City, UT 84112, USA. Electronic address: g.mohyuddin@hci.utah.edu.
2
Department of Medical Oncology and Molecular Oncology, Cancer Institute (WIA), Chennai, India.
3
Patient Advocates Working Group, Melanoma Patient Network Europe, European Society for Medical Oncology, Uppsala, Sweden.
4
Division of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.
PMID:
36055323
DOI:
10.1016/S2352-3026(22)00254-X
No abstract available
Publication types
Randomized Controlled Trial
MeSH terms
Humans
Vulnerable Populations*